152 related articles for article (PubMed ID: 37273452)
1. TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration.
Zhang H; Wang J; Yang J; He Q; Guan S; Qiao M; Zhao J; Wang X
Mediators Inflamm; 2023; 2023():5542181. PubMed ID: 37273452
[TBL] [Abstract][Full Text] [Related]
2. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
Front Genet; 2022; 13():908807. PubMed ID: 35832191
[No Abstract] [Full Text] [Related]
3. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
[TBL] [Abstract][Full Text] [Related]
4. Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma.
Guo F; Kong WN; Li DW; Zhao G; Wu HL; Anwar M; Shang XQ; Sun QN; Ma CL; Ma XM
Technol Cancer Res Treat; 2022; 21():15330338221106530. PubMed ID: 35730194
[No Abstract] [Full Text] [Related]
5. Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer.
Guo S; Jiang H; Deng Y; Dong Y; Yin A; Wang Q; Lan Q; Zhang Y; Xu C
J Obstet Gynaecol Res; 2023 Oct; 49(10):2475-2486. PubMed ID: 37497824
[TBL] [Abstract][Full Text] [Related]
6. CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction.
Guo X; Chen S; Wang S; Zhang H; Yin F; Guo P; Zhang X; Liu X; Han Y
Curr Oncol; 2022 Oct; 29(11):7994-8018. PubMed ID: 36354693
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity.
Huang J; Luo F; Shi M; Luo J; Ma C; Li S; Wei Y; Guo R; Li T
Aging (Albany NY); 2021 Dec; 13(23):25072-25088. PubMed ID: 34852326
[TBL] [Abstract][Full Text] [Related]
8. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer.
Lang X; Huang C; Cui H
J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
[TBL] [Abstract][Full Text] [Related]
9. GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer.
Shi YL; Liu MB; Wu HT; Han Y; He X
Dis Markers; 2022; 2022():9109365. PubMed ID: 35845139
[TBL] [Abstract][Full Text] [Related]
10. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
11. PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.
Li J; Kong WM
J Immunol Res; 2022; 2022():4510462. PubMed ID: 35497877
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
15. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
17. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Zhao J; Li H; Yuan M
Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657
[TBL] [Abstract][Full Text] [Related]
18. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
19. Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.
Chen C; Li HF; Hu YJ; Jiang MJ; Liu QS; Zhou J
Yonsei Med J; 2019 Jul; 60(7):611-618. PubMed ID: 31250574
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-378a-3p Downregulation as a Novel Biomarker with Poor Clinical Outcomes in Cervical Cancer.
Zhang L; Wu ZA
Biomed Environ Sci; 2021 Mar; 34(3):213-221. PubMed ID: 33766217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
